Discharge β-blocker use and race after coronary artery bypass grafting

Frontiers in Public Health

Volumn 2, Issue JUL, 2014, Pages

  O'Neal, Wesley T ^a   Efird, Jimmy T ^b   Davies, Stephen W ^c   O'Neal, Jason B ^d   Griffin, William F ^b   Ferguson, T Bruce ^b   Chitwood, W Randolph ^b   Kypson, Alan P ^b  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

^b EAST CAROLINA UNIVERSITY   (United States)

^c UNIVERSITY OF VIRGINIA   (United States)

^d HARVARD MEDICAL SCHOOL   (United States)

Author keywords

CABG; Cardiology; Epidemiology; Outcomes; blockers

Indexed keywords

EID: 84925313844     PISSN: None     EISSN: 22962565     Source Type: Journal    
DOI: 10.3389/fpubh.2014.00094     Document Type: Article

References (31)

1. Lloyd-Jones D, Adams RJ, Brown TM, Carnethon M, Dai S, De Simone G, et al. Executive summary: heart disease and stroke statistics -2010 update: a report from the American Heart Association. Circulation (2010) 121:948-54. doi:10.1161/CIRCULATIONAHA.109.192666
2. Heidenreich PA, Trogdon JG, Khavjou OA, Butler J, Dracup K, Ezekowitz MD, et al. Forecasting the future of cardiovascular disease in the United States: a policy statement from the American Heart Association. Circulation (2011) 123:933-44. doi:10.1161/CIR.0b013e31820a55f5
3. Ford ES, Capewell S. Proportion of the decline in cardiovascular mortality dis-ease due to prevention versus treatment: public health versus clinical care. Annu Rev Public Health (2011) 32:5-22. doi:10.1146/annurev-publhealth-031210-101211
4. Go AS, Mozaffarian D, Roger VL, Benjamin EJ, Berry JD, Borden WB, et al. Heart disease and stroke statistics -2013 update: a report from the American Heart Association. Circulation (2013) 127:e6-245. doi:10.1161/CIR. 0b013e31828124ad
5. Ford ES,AjaniUA,Croft JB,Critchley JA, LabartheDR,Kottke TE, et al. Explain-ing the decrease in U.S. deaths from coronary disease, 1980-2000. N Engl J Med (2007) 356:2388-98. doi:10.1056/NEJMsa053935
6. Maynard C, Fisher LD, Passamani ER. Survival of black persons compared with white persons in theCoronaryArtery Surgery Study (CASS).AmJCardiol (1987) 60:513-8. doi:10.1016/0002-9149(87)90296-7
7. Gray RJ,NessimS,Khan SS,Denton T,Matloff JM.Adverse 5-year outcome after coronary artery bypass surgery in blacks. Arch Intern Med (1996) 156:769-73. doi:10.1001/archinte.1996.00440070099011
8. Taylor HA Jr, Mickel MC, Chaitman BR, Sopko G, Cutter GR, Rogers WJ. Long-term survival of African Americans in the Coronary Artery Surgery Study (CASS). JAmCollCardiol (1997) 29:358-64. doi:10.1016/S0735-1097(96) 00500-1
9. Brooks MM, Jones RH, Bach RG, Chaitman BR, Kern MJ, Orszulak TA, et al. Predictors of mortality and mortality from cardiac causes in the bypass angio-plasty revascularization investigation (BARI) randomized trial and registry. For the BARI investigators. Circulation (2000) 101:2682-9. doi:10.1161/01.CIR.101. 23.2682
10. Cooper WA, Thourani VH, Guyton RA, Kilgo P, Lattouf OM, Chen EP, et al. Racial disparity persists after on-pump and off-pump coronary artery bypass grafting. Circulation (2009) 120:S59-64. doi:10.1161/CIRCULATIONAHA.108. 843763
11. Goyal A, Alexander JH, Hafley GE, Graham SH, Mehta RH, Mack MJ, et al. Outcomes associated with the use of secondary prevention medications after coronary artery bypass graft surgery. Ann Thorac Surg (2007) 83:993-1001. doi:10.1016/j.athoracsur.2006.10.046
12. Chan AY,Mcalister FA, Norris CM, Johnstone D, Bakal JA, Ross DB, et al. Effect of beta-blocker use on outcomes after discharge in patients who underwent cardiac surgery. J Thorac Cardiovasc Surg (2010) 140:182-7. doi:10.1016/j.jtcvs. 2010.03.015
13. Angeloni E, Melina G, Roscitano A, Refice S, Capuano F, Lechiancole A, et al. β-blockers improve survival of patients with chronic obstructive pulmonary disease after coronary artery bypass grafting.AnnThorac Surg (2013) 95:525-31. doi:10.1016/j.athoracsur.2012.07.080
14. Lanfear DE, Hrobowski TN, Peterson EL, Wells KE, Swadia TV, Spertus JA, et al. Association of beta-blocker exposure with outcomes in heart failure differs between African American and white patients. Circ Heart Fail (2012) 5:202-8. doi:10.1161/CIRCHEARTFAILURE.111.965780
15. Efird JT, O'Neal WT, Anderson CA, O'Neal JB, Kindell LC, Ferguson TB, et al. The effect of race and chronic obstructive pulmonary disease on long-term survival after coronary artery bypass grafting. Front Public Health (2013) 1:4. doi:10.3389/fpubh.2013.00004
16. Efird JT, O'Neal WT, O'Neal JB, Ferguson TB, Chitwood WR, Kypson AP. Effect of peripheral arterial disease and race on survival after coronary artery bypass grafting. Ann Thorac Surg (2013) 96:112-8. doi:10.1016/j.athoracsur. 2013.04.006
17. O'Neal WT, Efird JT, Anderson CA, Kindell LC, O'Neal JB, Bruce Ferguson T, et al. The impact of prior percutaneous coronary intervention on long-term survival after coronary artery bypass grafting. Heart Lung Circ (2013) 22:940-5. doi:10.1016/j.hlc.2013.04.110
18. North Carolina Facts. Available from: http://www.indexmundi.com/facts/united-states/quick-facts/north-carolina [cited 2014 Jan 18].
19. Morales DL,Mcclellan AJ, Jacobs JP. Empowering a database with national long-term data about mortality: the use of national death registries. Cardiol Young (2008) 18:188-95. doi:10.1017/S1047951108002916
20. da Graca B, Filardo G, Nicewander D. Consequences for healthcare quality and research of the exclusion of records from the death master file. Circ Cardiovasc Qual Outcomes (2013) 6:124-8. doi:10.1161/CIRCOUTCOMES.112.968826
21. Grambsch P, Therneau T. Proportional hazards tests and diagnostics based on weighted residuals. Biometrika (1994) 81:515-26. doi:10.1093/biomet/81.3.515
22. Ferguson TB Jr,Coombs LP,Peterson ED; Society of Thoracic SurgeonsNational Adult Cardiac Surgery Database. Preoperative beta-blocker use and mortal-ity and morbidity following CABG surgery in North America. JAMA (2002) 287:2221-7. doi:10.1001/jama.287.17.2221
23. BrinkmanWT, Herbert MA, Prince SL,Magee MJ, Dewey TM, Smith RL, et al. Preoperative beta-blocker usage: is it really worthy of being a quality indicator? Ann Thorac Surg (2011) 92:788-95. doi:10.1016/j.athoracsur.2011.03.088
24. Cresci S, Kelly RJ, Cappola TP, Diwan A, Dries D, Kardia SL, et al. Clinical and genetic modifiers of long-termsurvival in heart failure. J AmColl Cardiol (2009) 54:432-44. doi:10.1016/j.jacc.2009.05.009
25. Cresci S, Dorn GW II, Jones PG, Beitelshees AL, Li AY, Lenzini PA, et al. Adrenergic-pathway gene variants influence beta-blocker-related outcomes after acute coronary syndrome in a race-specific manner. J Am Coll Cardiol (2012) 60:898-907. doi:10.1016/j.jacc.2012.02.051
26. Koch CG, Li L,Kaplan GA,Wachterman J, ShishehborMH, Sabik J, et al. Socioe-conomic position, not race, is linked to death after cardiac surgery. Circ Car-diovasc Qual Outcomes (2010) 3:267-76. doi:10.1161/CIRCOUTCOMES.109. 880377
27. Maheshwari A, Dalton JE, Yared JP, Mascha EJ, Kurz A, Sessler DI. The asso-ciation between alcohol consumption and morbidity and mortality in patients undergoing coronary artery bypass surgery. J Cardiothorac Vasc Anesth (2010) 24:580-5. doi:10.1053/j.jvca.2009.09.003
28. Okrainec K, Pilote L, Platt R, Eisenberg MJ. Use of cardiovascular med-ical therapy among patients undergoing coronary artery bypass graft surgery: results from the ROSETTA-CABG registry. Can J Cardiol (2006) 22:841-7. doi:10.1016/S0828-282X(06)70302-6
29. Efird JT, Lea S, Toland A, Phillips CJ. Informational odds ratio: a useful measure of epidemiologic association in environment exposure studies. Environ Health Insights (2012) 6:17-25. doi:10.4137/EHI.S9236
30. Breiman L. Random forests. Mach Learn (2001) 45:5-32. doi:10.1023/A: 1017934522171
31. Lee BK, Lessler J, Stuart EA. Improving propensity score weighting using machine learning. Stat Med (2010) 29:337-46. doi:10.1002/sim.3782